Terns Pharmaceuticals, Inc. (MUN:430) Financings

Terns Pharmaceuticals, Inc.

Financings

RaiseDate
Public offering of common stock
Closed: US$747.5M raised · US$40 a share · Jefferies +5
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Leerink Partners (co-lead), Mizuho, Citizens Capital Markets, Oppenheimer & Co.
Use of proceeds: Research, clinical trials, development and manufacturing of product candidates including TERN-701, pre-launch activities, working capital and general purposes
Dec 11, 2025

Read by 6ix AI from the company's releases